Kumiko Arai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kumiko Arai has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Kenichi Ikejima
Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan
5 shared publications - Shunhei Yamashina
Department of Gastroenterology, Juntendo University Graduate School of Medicine, Tokyo, Japan
5 shared publications - Kazuyoshi Kon
Department of Gastroenterology Juntendo University school of Medicine Tokyo Japan
4 shared publications - Akira Uchiyama
Department of Gastroenterology Juntendo University school of Medicine Tokyo Japan
3 shared publications - Gentaro Taniguchi
Department of Molecular Pathology, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
1 shared publication H. Ganno
1 shared publication
Latest Publications
- 19 June 2026
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 393 (8) , 104971
Glycine attenuates double-stranded RNA-induced autoimmune cholangitis and pancreatitis by modulating innate immune signaling in mice
- 19 June 2026
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 393 (8) , 104971
Glycine attenuates double-stranded RNA-induced autoimmune cholangitis and pancreatitis by modulating innate immune signaling in mice
- 6 February 2020
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 35 (8) , 1437-1448
Aging exacerbates high‐fat diet‐induced steatohepatitis through alteration in hepatic lipid metabolism in mice
Background and Aim Aging is an independent risk factor for the progression of nonalcoholic steatohepatitis (NASH). Here we investigated the role of age‐related alterations in fatty acid metabolism in dietary steatohepatitis using lipidomics analysis. Methods Male, 8‐ and 55‐week‐old C57BL/6J mice were fed a high‐fat diet (HFD) for 8 weeks. The quality and quantity of lipid molecular species in the liver were evaluated using the lipidomics approach. Results Elder mice fed a HFD developed more severe steatohepatitis than young mice. Oxidative stress and inflammatory cytokines in the liver were exacerbated following HFD feeding in elder mice compared to young mice. In elder mice, de novo fatty‐acid synthesis was promoted, whereas β oxidation was blunted following HFD feeding, and lipid secretion from the liver was reduced. The expression of sirtuin 1 (SIRT1) was not only reduced with age as expected but also significantly decreased due to intake of HFD. In the lipidomics analysis, the concentration of diacylglycerol (DAG) and TAG molecular species containing monounsaturated fatty acids (MUFA) were markedly increased following HFD feeding in elder mice compared to young mice. In contrast, the concentration of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) molecular species containing polyunsaturated fatty acids (PUFA) were remarkably decreased following HFD feeding in elder mice compared to young mice, and the expression of fatty acid desaturase was blunted. Conclusions Aging‐dependent alterations in lipid metabolism under excessive lipid supply most likely enhance hepatic lipotoxicity, thereby exacerbating metabolic steatohepatitis in elderly.
- 6 February 2020
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 35 (8) , 1437-1448
Aging exacerbates high‐fat diet‐induced steatohepatitis through alteration in hepatic lipid metabolism in mice
Background and Aim Aging is an independent risk factor for the progression of nonalcoholic steatohepatitis (NASH). Here we investigated the role of age‐related alterations in fatty acid metabolism in dietary steatohepatitis using lipidomics analysis. Methods Male, 8‐ and 55‐week‐old C57BL/6J mice were fed a high‐fat diet (HFD) for 8 weeks. The quality and quantity of lipid molecular species in the liver were evaluated using the lipidomics approach. Results Elder mice fed a HFD developed more severe steatohepatitis than young mice. Oxidative stress and inflammatory cytokines in the liver were exacerbated following HFD feeding in elder mice compared to young mice. In elder mice, de novo fatty‐acid synthesis was promoted, whereas β oxidation was blunted following HFD feeding, and lipid secretion from the liver was reduced. The expression of sirtuin 1 (SIRT1) was not only reduced with age as expected but also significantly decreased due to intake of HFD. In the lipidomics analysis, the concentration of diacylglycerol (DAG) and TAG molecular species containing monounsaturated fatty acids (MUFA) were markedly increased following HFD feeding in elder mice compared to young mice. In contrast, the concentration of phosphatidylethanolamine (PE) and phosphatidylcholine (PC) molecular species containing polyunsaturated fatty acids (PUFA) were remarkably decreased following HFD feeding in elder mice compared to young mice, and the expression of fatty acid desaturase was blunted. Conclusions Aging‐dependent alterations in lipid metabolism under excessive lipid supply most likely enhance hepatic lipotoxicity, thereby exacerbating metabolic steatohepatitis in elderly.
- Open Access
- 1 November 2019
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 317 (5) , G707-G715
Rifaximin prevents ethanol-induced liver injury in obese KK-Ay mice through modulation of small intestinal microbiota signature
Exacerbation of alcoholic hepatitis (AH) with comorbid metabolic syndrome is an emerging clinical problem, where microbiota plays a profound role in the pathogenesis. Here, we investigated the effect of rifaximin (RFX) on liver injury following chronic-binge ethanol (EtOH) administration in KK-Ay mice, a rodent model of metabolic syndrome. Female, 8-wk-old KK-Ay mice were fed Lieber–DeCarli diet (5% EtOH) for 10 days, following a single EtOH gavage (4 g/kg body wt). Some mice were given RFX (0.1 g/L, in liquid diet) orally. Small intestinal contents were collected from mice without binge. Intestinal microbiota was quantified using aerobic and anaerobic culturing techniques and further analyzed by 16S rRNA sequencing in detail. EtOH feeding/binge caused hepatic steatosis, oxidative stress, and induction of inflammatory cytokines in KK-Ay mice, which were markedly prevented by RFX treatment. Hepatic mRNA levels for cluster of differentiation 14, Toll-like receptor (TLR) 4, TLR2, and NADPH oxidase 2 were increased following EtOH feeding/binge, and administration of RFX completely suppressed their increase. The net amount of small intestinal bacteria was increased over threefold after chronic EtOH feeding as expected; however, RFX did not prevent this net increase. Intriguingly, the profile of small intestinal microbiota was dramatically changed following EtOH feeding in the order level, where the Erysipelotrichales predominated in the relative abundance. In sharp contrast, RFX drastically blunted the EtOH-induced increases in the Erysipelotrichales almost completely, with increased proportion of the Bacteroidales. In conclusion, RFX prevents AH through modulation of small intestinal microbiota/innate immune responses in obese KK-Ay mice. NEW & NOTEWORTHY Here we demonstrated that rifaximin (RFX) prevents chronic-binge ethanol (EtOH)-induced steatohepatitis in KK-Ay mice. Chronic EtOH feeding caused small intestinal bacterial overgrowth, with drastic alteration in the microbiota profile predominating the order Erysipelotrichales. RFX minimized this EtOH induction in Erysipelotrichales with substitutive increases in Bacteroidales. RFX also prevented EtOH-induced increases in portal lipopolysaccharide, and hepatic cluster of differentiation 14, toll-like receptor (TLR) 2, and TLR4 mRNA levels, suggesting the potential involvement of microbiota-related innate immune responses.
- 1 November 2019
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 317 (5) , G707-G715
Open AccessRifaximin prevents ethanol-induced liver injury in obese KK-Ay mice through modulation of small intestinal microbiota signature
Exacerbation of alcoholic hepatitis (AH) with comorbid metabolic syndrome is an emerging clinical problem, where microbiota plays a profound role in the pathogenesis. Here, we investigated the effect of rifaximin (RFX) on liver injury following chronic-binge ethanol (EtOH) administration in KK-Ay mice, a rodent model of metabolic syndrome. Female, 8-wk-old KK-Ay mice were fed Lieber–DeCarli diet (5% EtOH) for 10 days, following a single EtOH gavage (4 g/kg body wt). Some mice were given RFX (0.1 g/L, in liquid diet) orally. Small intestinal contents were collected from mice without binge. Intestinal microbiota was quantified using aerobic and anaerobic culturing techniques and further analyzed by 16S rRNA sequencing in detail. EtOH feeding/binge caused hepatic steatosis, oxidative stress, and induction of inflammatory cytokines in KK-Ay mice, which were markedly prevented by RFX treatment. Hepatic mRNA levels for cluster of differentiation 14, Toll-like receptor (TLR) 4, TLR2, and NADPH oxidase 2 were increased following EtOH feeding/binge, and administration of RFX completely suppressed their increase. The net amount of small intestinal bacteria was increased over threefold after chronic EtOH feeding as expected; however, RFX did not prevent this net increase. Intriguingly, the profile of small intestinal microbiota was dramatically changed following EtOH feeding in the order level, where the Erysipelotrichales predominated in the relative abundance. In sharp contrast, RFX drastically blunted the EtOH-induced increases in the Erysipelotrichales almost completely, with increased proportion of the Bacteroidales. In conclusion, RFX prevents AH through modulation of small intestinal microbiota/innate immune responses in obese KK-Ay mice. NEW & NOTEWORTHY Here we demonstrated that rifaximin (RFX) prevents chronic-binge ethanol (EtOH)-induced steatohepatitis in KK-Ay mice. Chronic EtOH feeding caused small intestinal bacterial overgrowth, with drastic alteration in the microbiota profile predominating the order Erysipelotrichales. RFX minimized this EtOH induction in Erysipelotrichales with substitutive increases in Bacteroidales. RFX also prevented EtOH-induced increases in portal lipopolysaccharide, and hepatic cluster of differentiation 14, toll-like receptor (TLR) 2, and TLR4 mRNA levels, suggesting the potential involvement of microbiota-related innate immune responses.
- 1 September 2012
- Published by Elsevier in Clinical Nutrition Supplements
- Vol. 7 (1) , 247-248
PP277-MON IRON STATUS WAS NOT IMPROVED BY POSTOPERATIVE INTRAVENOUS IRON SUPPLY
- 1 September 2012
- Published by Elsevier in Clinical Nutrition Supplements
- Vol. 7 (1) , 247-248
PP277-MON IRON STATUS WAS NOT IMPROVED BY POSTOPERATIVE INTRAVENOUS IRON SUPPLY
- Open Access
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
High Fat Diet Increases Susceptibility to Hypoxia-Induced Zone 3-Dominant Hepatocyte Apoptosis in Mice
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Open AccessHigh Fat Diet Increases Susceptibility to Hypoxia-Induced Zone 3-Dominant Hepatocyte Apoptosis in Mice
- Open Access
- 1 January 2008
- Published by Elsevier in Journal of Hepatology
- Vol. 48, S180
474 C-REACTIVE PROTEIN ATTENUATES EXPERIMENTAL HEPATIC FIBROSIS THROUGH INHIBITION OF HEPATIC STELLATE CELL TRANSACTIVATION
- 1 January 2008
- Published by Elsevier in Journal of Hepatology
- Vol. 48, S180
Open Access474 C-REACTIVE PROTEIN ATTENUATES EXPERIMENTAL HEPATIC FIBROSIS THROUGH INHIBITION OF HEPATIC STELLATE CELL TRANSACTIVATION